NCT06636734 2026-02-11
Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial
Emory University
Phase 2 Recruiting
Clinical Trials
13 trialsNCT02964884 2025-06-24
Interventions for Reading Disabilities in NF1
Vanderbilt University
Phase 2 Active not recruiting
NCT03504501 2023-11-30
SynCoRAS
Technical University of Munich
Phase 2 Terminated
NCT03826940 2021-04-02
ASD/NF1inhib
University of Coimbra
Phase NA Completed
NCT01478828 2019-03-27
Pre-Prostatectomy Lovastatin on Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Terminated
NCT00584012 2018-10-19
A Study of the Proper Dosage of Lovastatin and Docetaxel for Patients With Cancer
University of Iowa
Phase 1 Terminated
NCT00853580 2018-03-12
STARS
University of Alabama at Birmingham
Phase 2 Completed
NCT00583102 2018-01-05
Dose Escalation Phase I/II Study of Lovastatin With High-Dose Cytarabine for Refractory or Relapsed AML
University of Iowa
Phase 1/2 Terminated
NCT00585052 2018-01-05
A Phase II Study of Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian Cancer
University of Iowa
Phase 2 Terminated
NCT00352599 2016-11-22
NF1
University of California, Los Angeles
Phase 1 Completed
NCT00580970 2016-11-18
Study of Effectiveness of Lovastatin to Prevent Radiation-Induced Rectal Injury
Virginia Commonwealth University
Phase 2 Completed
NCT00902668 2013-06-20
Lovastatin in Reducing Side Effects After Radiation Therapy in Women With Breast Cancer
Virginia Commonwealth University
Phase 2 Terminated
NCT00963664 2009-09-09
Evaluation of Interferon-Lovastatin Therapy for Malignant Melanoma
NeoPlas Innovation
Phase 2 Withdrawn